Cyclerion Therapeutics (CYCN) Other Non Operating Income (2023 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Other Non Operating Income of $30000.0 in Q3 2025, down 3.23% quarter-over-quarter from $31000.0 in Q2 2025, and down 28.57% on a YoY basis from $42000.0 in Q3 2024.
Cyclerion Therapeutics (CYCN) Other Non Operating Income (2023 - 2025) Analysis & Trends
Cyclerion Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $30000.0 for Q3 2025.
- In Q3 2025, Other Non Operating Income fell 28.57% year-over-year to $30000.0; the TTM figure through Sep 2025 stood at $117000.0 (down 58.36% YoY), while the FY2024 annual figure was $208000.0, down 41.9% from the prior year.
- Other Non Operating Income was $30000.0 for Q3 2025 at Cyclerion Therapeutics, down from $31000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $107000.0 in Q3 2023 to a low of $28000.0 in Q4 2024.
- Historically, Other Non Operating Income has averaged $56111.1 across 3 years, with a median of $42000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income tumbled 72.28% in 2024, then dropped 28.57% in 2025.
- A 3-year view of Other Non Operating Income shows it stood at $101000.0 in 2023, then sank by 72.28% to $28000.0 in 2024, then rose by 7.14% to $30000.0 in 2025.
- The last three Other Non Operating Income figures came in at $30000.0 (Q3 2025), $31000.0 (Q2 2025), and $28000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 76,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | 107,000.00 |